MENU
NTLA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Intellia Therapeutics (NTLA) Earnings Date & Reports
Intellia Therapeutics is a gene-editing company focused on the development of Crispr/Cas9-based therapeutics... Show more
Industry: #Biotechnology
A.I. Advisor
published Earnings
NTLA is expected to report earnings to fall 1.02% to -80 cents per share on July 30
Q2'26
Est.
$-0.80
Q1'26
Beat
by $0.10
Q4'25
Beat
by $0.13
Q3'25
Beat
by $0.09
Q2'25
Beat
by $0.05
The last earnings report on May 11 showed earnings per share of -81 cents, beating the estimate of -91 cents. With 3.84M shares outstanding, the current market capitalization sits at 1.82B.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information
General Information
a developer of proprietary, potentially curative therapeutics
Industry Biotechnology
Profile
Details
Industry
Biotechnology
Address
40 Erie Street
Phone
+1 857 285-6200
Employees
377
Web
https://www.intelliatx.com